Mesoscopic Detection of Focal Cortical Signal Alterations
- Conditions
- D33.9Q04.9Central nervous system, unspecifiedCongenital malformation of brain, unspecified
- Registration Number
- DRKS00008794
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Patients with Dysembryoplastic Neuroectodermal Tumors, Gangliogliomas and Focal Cortical Dysplasias and preoperative 3D- and diffusion imaging.
Exclusion Criteria
Poor image quality
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The calculation of diffusion parameters of each pathology.
- Secondary Outcome Measures
Name Time Method Group-wise comparison of the diffusion parameters using parametric or non-parametric tests.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neuroimaging techniques are used in DRKS00008794 to detect focal cortical signal alterations in D33.9 and Q04.9 patients?
Which biomarkers correlate with focal cortical signal changes in DRKS00008794 for D33.9 and Q04.9 conditions?
What are the common adverse events observed in DRKS00008794 for patients with unspecified CNS and brain malformations?
How do findings from DRKS00008794 compare to other observational studies on cortical signal alterations in Q04.9 malformations?
What molecular pathways are implicated in focal cortical signal alterations identified in DRKS00008794 for D33.9 and Q04.9?